SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-292014
Filing Date
2022-11-23
Accepted
2022-11-23 16:06:02
Documents
14
Period of Report
2022-11-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d205981d8k.htm   iXBRL 8-K 26461
2 EX-10.1 d205981dex101.htm EX-10.1 14622
6 GRAPHIC g205981g13n75.jpg GRAPHIC 10642
  Complete submission text file 0001193125-22-292014.txt   184762

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bior-20221121.xsd EX-101.SCH 2869
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bior-20221121_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bior-20221121_pre.xml EX-101.PRE 11720
8 EXTRACTED XBRL INSTANCE DOCUMENT d205981d8k_htm.xml XML 3479
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 221416385
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences